KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Exact Sciences (EXAS) over the last 12 years, with Q4 2025 value amounting to $1.4 million.

  • Exact Sciences' Change in Inventory fell 9442.41% to $1.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.8 million, marking a year-over-year decrease of 8919.54%. This contributed to the annual value of $3.8 million for FY2025, which is 8919.54% down from last year.
  • As of Q4 2025, Exact Sciences' Change in Inventory stood at $1.4 million, which was down 9442.41% from -$6.7 million recorded in Q3 2025.
  • In the past 5 years, Exact Sciences' Change in Inventory registered a high of $25.4 million during Q4 2024, and its lowest value of -$6.7 million during Q3 2025.
  • Moreover, its 5-year median value for Change in Inventory was $1.8 million (2022), whereas its average is $3.4 million.
  • In the last 5 years, Exact Sciences' Change in Inventory skyrocketed by 167016.57% in 2024 and then plummeted by 33979.33% in 2025.
  • Exact Sciences' Change in Inventory (Quarter) stood at $8.1 million in 2021, then plummeted by 56.63% to $3.5 million in 2022, then tumbled by 252.69% to -$5.4 million in 2023, then surged by 571.68% to $25.4 million in 2024, then crashed by 94.42% to $1.4 million in 2025.
  • Its Change in Inventory was $1.4 million in Q4 2025, compared to -$6.7 million in Q3 2025 and -$5.1 million in Q2 2025.